Posts

Showing posts with the label Atopic Dermatitis Drug Market Trends

Atopic Dermatitis Drug Market Strategic Assessment And Forecast 2018-2026

Atopic dermatitis, also known as eczema, is a condition in which skin becomes dry, itchy, and inflamed, which leads to redness, swelling, scaling, and crusting.  Atopic dermatitis is commonly found in children under one year. The exact cause of atopic dermatitis is undiscovered, but it is believed that it includes genetics, environmental exposure, immune system dysfunction, and problem with skin permeability. Dry climate is also a major cause of atopic dermatitis. This disease is non-contagious and easily diagnosed with signs and symptoms such as swelling and redness of skin. Many people with atopic dermatitis develop asthma and hay fever. Atopic dermatitis treatment involves photo therapy, steroid pills, calcineurin inhibitors ointment, biologic agents such as immunologic, monoclonal antibody, and dietary changes in case of food allergy. Request For A Sample Copy Of This Research Report: https://www.coherentmarketinsights.com/insight/request-sample/712 Topical steroi...